ArticleFrontiers in immunology2026

Accelerated response and reduced chemotherapy with ruxolitinib-based regimen therapy in pediatric hemophagocytic lymphohistiocytosis: a retrospective comparison with HLH-94 regimen.

Na Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.